产品编号：D445874
产品规格：25mg
产品价格：面议
| 标准品编号: | D445874 |
| 名称: | 6-Desacetyl-6-bromo-N-Boc Palbociclib-d4 |
| 别名: | 4-[6-[(6-Bromo-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazine-2,2,6,6-d4-carboxylic-d4 Acid 1,1-Dimethylethyl Ester; tert-Butyl 4-[6-(6-Bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidin-2-ylamino)-pyridin-3-yl]-piperazine-1-carboxylate-d4 |
| CAS号: | 2089333-16-2 |
| 参考CAS号: | 类似: 571188-82-4 |
| 分子式: | C₂₇H₃₀D₄BrN₇O₃ |
| 外观: | Yellow Solid |
| 分子量: | 588.53 |
| 溶解性: | DMF, Methanol (heat) |
| 种类: | Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | 6-Desacetyl-6-bromo-N-Boc Palbociclib-d4 is an intermediate in synthesizing Palbociclib-d4 (P139901), an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
| 参考文献 | |
